Professor, Medicine, University of Miami School of Medicine
Endocrinology
Dr. Jay M. Sosenko, MD
|
|
Give Review
Jay M. Sosenko, MD practices Endocrinology. He graduated from Temple University School of Medicine. Jay M. Sosenko is a published doctor. He published 69 publications, including: 'A prospective study of sensory function in patients with type 2 diabetes.'
Publications
- The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months.
- A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History.
- The Acceleration of the Loss of the First-Phase Insulin Response during the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants.
- Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver operating characteristic analysis.
- The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.
- The Application of the Diabetes Prevention Trial-Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes.
- The prevalence of diabetic neuropathy according to ethnicity.
- Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.
- Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.
- Sensory function and albumin excretion according to diagnostic criteria for diabetes.
- Diabetic somatic neuropathies.
- Prevention of type 1 diabetes: the time has come.
- Unusually difficult challenges in human-subjects research.
- The epidemiology of neuropathic foot ulcers in individuals with diabetes.
- Albuminuria in recent-onset type 2 diabetes: the Strong Heart Study.
- Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy.
- A prospective study of sensory function in patients with type 2 diabetes.
- NBME Examination Part I as a predictor of clinical and ABIM certifying examination performances.
- A comparison of adiposity measures for screening non-insulin dependent diabetes mellitus.
- Plasma lipid levels at diagnosis in type 2 diabetic patients.
- The degree of blood pressure evaluation and end organ damage with severe hypertension: a case-control study.
- Use of a premixed insulin regimen (Novolin 70/30) to replace self-mixed insulin regimens.
- Glycosylation of variant hemoglobins in normal and diabetic subjects.
- Familial aggregation of total cholesterol, high density lipoprotein cholesterol and total triglyceride levels in plasma.
- Obesity, sodium intake, and blood pressure in adolescents.
- Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients.
- Hyperglycemia and plasma lipid levels: covariations in insulin-dependent diabetes.
- Umbilical cord glycosylated hemoglobin in infants of diabetic mothers: relationships to neonatal hypoglycemia, macrosomia, and cord serum C-peptide.
- Muscle capillary basement-membrane thickness and long-term glycemia in type I diabetes mellitus.
- The vibratory perception threshold in young diabetic patients: associations with glycemia and puberty.
- Attribute frequency and misclassification bias.
- Body stature as a risk factor for diabetic sensory neuropathy.
- Use of plaster casts in the management of diabetic neuropathic foot ulcers.
- Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy.
- Neurofunctional testing for the detection of diabetic peripheral neuropathy.
- Blood pressure, insulin, and glycemia in nondiabetic subjects.
- The association between heart rate and glycemia in adult diabetic subjects.
- Specific assessments of warm and cool sensitivities in adult diabetic patients.
- The association between symptomatic sensory neuropathy and body stature in diabetic patients.
- High-density lipoprotein and glycosylated hemoglobin in nondiabetic individuals.
- Impaired vibratory perception and diabetic foot ulceration.
- NPH human insulin: does it work in a once-a-day regimen?
- Determinants of quantitative sensory testing in non-neuropathic individuals.
- The relation between the plasma lipoprotein pattern and the waist/hip ratio in non-diabetic individuals.
- Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients.
- Comparison of the lipid profiles of Cubans and other Hispanics with non-Hispanics.
- The prevalence and extent of vibration sensitivity impairment in men with chronic ethanol abuse.
- Sensory function at diagnosis and in early stages of NIDDM in patients detected through screening.
- The relationship of total lymphocyte count to CD4 lymphocyte counts in patients infected with human immunodeficiency virus.
- Glycosylated hemoglobins: increased glycosylation of hemoglobin A in diabetic patients.
- Incidence of lower-extremity amputation in American Indians: the Strong Heart Study.
- A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.
- Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabe...
- A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.
- Development of autoantibodies in the TrialNet Natural History Study.
- Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study.
- Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood.
- Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes.
- Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).
- A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants.
- Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
- Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset.
- A comparison of the monofilament with other testing modalities for foot ulcer susceptibility.
- Diabetic neuropathies: a statement by the American Diabetes Association.
- Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.
- Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.
- The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.
- ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.
Schools
Temple University School Of Medicine
UCLA Med Center
Doctors Specialties
- Internal Medicine
- Endocrinology
Accepted Insurances
Education
-
Boston Children's Hospital -
UCLA Medical Center -
Temple University School of Medicine
Hospital
-
University of Miami Hospital -
Miami Veterans Affairs Healthcare System
Helpful Reviews
Similar Doctors
|
|
Dr. Bresta Y. Miranda-Palma, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vitor H. Pastorini Filho, MD |
|
|
Dr. Daniel F. Garcia, MD |
|
|
Dr. Jack L. Gabay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Atil Y. Kargi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marisabel Bravo, DO |
|
Dr. Hernan Baquerizo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luis R. Florez, MD |
|
|
Dr. Marianne Madiedo, MD
This Doctor is OpenDoctor Recommended.
|